Skip to main content
Top
Published in: Digestive Diseases and Sciences 12/2017

01-12-2017 | Original Article

Association of Helicobacter pylori with the Risk of Hepatic Encephalopathy

Authors: Karn Wijarnpreecha, Supavit Chesdachai, Charat Thongprayoon, Veeravich Jaruvongvanich, Patompong Ungprasert, Wisit Cheungpasitporn

Published in: Digestive Diseases and Sciences | Issue 12/2017

Login to get access

Abstract

Background/Objectives

Hepatic encephalopathy is the common manifestation of decompensated cirrhosis. The association between Helicobacter pylori (H. pylori) infection and hepatic encephalopathy has been shown in many epidemiologic studies. This meta-analysis was conducted to summarize all available studies to estimate the association between H. pylori infection and hepatic encephalopathy.

Methods

A comprehensive literature review was conducted using MEDLINE and EMBASE database through March 2017 to identify studies that reported the association between H. pylori infection and hepatic encephalopathy. Effect estimates from the individual study were extracted and combined using random-effect, generic inverse variance method of DerSimonian and Laird.

Results

Of 15,233 studies, eleven studies (four cross-sectional, four case–control, and three cohort studies) met the eligibility criteria and were included in the meta-analysis. The pooled OR of hepatic encephalopathy in patients with H. pylori infection was 1.73 (95% CI 1.09–2.73) when compared with the patients without H. pylori infection. The association between H. pylori and hepatic encephalopathy was not statistically significant after the sensitivity analysis, excluding those using ELISA alone, with a pooled OR of 1.92 (95% CI 0.91–4.05, I 2 = 62%). There was no publication bias of overall included studies assessed by the funnel plots and Egger’s regression asymmetry test.

Conclusions

This study demonstrated a potential association between H. pylori infection and risk of hepatic encephalopathy. Future studies are required to assess the effect of chronicity of infection on the development of hepatic encephalopathy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther. 1995;9:33–39.PubMed Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther. 1995;9:33–39.PubMed
2.
go back to reference Siurala M, Sipponen P, Kekki M. Campylobacter pylori in a sample of Finnish population: relations to morphology and functions of the gastric mucosa. Gut. 1988;29:909–915.CrossRefPubMedPubMedCentral Siurala M, Sipponen P, Kekki M. Campylobacter pylori in a sample of Finnish population: relations to morphology and functions of the gastric mucosa. Gut. 1988;29:909–915.CrossRefPubMedPubMedCentral
3.
go back to reference Jiang J, Chen Y, Shi J, Song C, Zhang J, Wang K. Population attributable burden of Helicobacter pylori-related gastric cancer, coronary heart disease, and ischemic stroke in China. Eur J Clin Microbiol Infect Dis. 2017;36:199–212.CrossRefPubMed Jiang J, Chen Y, Shi J, Song C, Zhang J, Wang K. Population attributable burden of Helicobacter pylori-related gastric cancer, coronary heart disease, and ischemic stroke in China. Eur J Clin Microbiol Infect Dis. 2017;36:199–212.CrossRefPubMed
4.
go back to reference Laine L. Helicobacter pylori, gastric ulcer, and agents noxious to the gastric mucosa. Gastroenterol Clin N Am. 1993;22:117–125. Laine L. Helicobacter pylori, gastric ulcer, and agents noxious to the gastric mucosa. Gastroenterol Clin N Am. 1993;22:117–125.
5.
go back to reference Goni E, Franceschi F. Helicobacter pylori and extragastric diseases. Helicobacter. 2016;21:45–48.CrossRefPubMed Goni E, Franceschi F. Helicobacter pylori and extragastric diseases. Helicobacter. 2016;21:45–48.CrossRefPubMed
6.
go back to reference Kyburz A, Muller A. Helicobacter pylori and extragastric diseases. Curr Top Microbiol Immunol. 2017;400:325–347.PubMed Kyburz A, Muller A. Helicobacter pylori and extragastric diseases. Curr Top Microbiol Immunol. 2017;400:325–347.PubMed
7.
go back to reference Wijarnpreecha K, Thongprayoon C, Nissaisorakarn P, et al. Association of Helicobacter pylori with chronic kidney diseases: a meta-analysis. Dig Dis Sci. 2017;62:2045–2052.CrossRefPubMed Wijarnpreecha K, Thongprayoon C, Nissaisorakarn P, et al. Association of Helicobacter pylori with chronic kidney diseases: a meta-analysis. Dig Dis Sci. 2017;62:2045–2052.CrossRefPubMed
8.
go back to reference Wijarnpreecha K, Thongprayoon C, Nissaisorakarn P, et al. Association between Helicobacter pylori and end-stage renal disease: a meta-analysis. World J Gastroenterol. 2017;23:1497–1506.CrossRefPubMedPubMedCentral Wijarnpreecha K, Thongprayoon C, Nissaisorakarn P, et al. Association between Helicobacter pylori and end-stage renal disease: a meta-analysis. World J Gastroenterol. 2017;23:1497–1506.CrossRefPubMedPubMedCentral
10.
go back to reference Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol. 2001;96:2718–2723.CrossRefPubMed Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol. 2001;96:2718–2723.CrossRefPubMed
11.
go back to reference Ortiz M, Cordoba J, Jacas C, Flavia M, Esteban R, Guardia J. Neuropsychological abnormalities in cirrhosis include learning impairment. J Hepatol. 2006;44:104–110.CrossRefPubMed Ortiz M, Cordoba J, Jacas C, Flavia M, Esteban R, Guardia J. Neuropsychological abnormalities in cirrhosis include learning impairment. J Hepatol. 2006;44:104–110.CrossRefPubMed
12.
go back to reference Dhiman RK, Saraswat VA, Sharma BK, et al. Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver. J Gastroenterol Hepatol. 2010;25:1029–1041.CrossRefPubMed Dhiman RK, Saraswat VA, Sharma BK, et al. Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver. J Gastroenterol Hepatol. 2010;25:1029–1041.CrossRefPubMed
13.
go back to reference Maldonado-Garza HJ, Vazquez-Elizondo G, Gaytan-Torres JO, Flores-Rendon AR, Cardenas-Sandoval MG, Bosques-Padilla FJ. Prevalence of minimal hepatic encephalopathy in cirrhotic patients. Ann Hepatol. 2011;10:S40–S44.PubMed Maldonado-Garza HJ, Vazquez-Elizondo G, Gaytan-Torres JO, Flores-Rendon AR, Cardenas-Sandoval MG, Bosques-Padilla FJ. Prevalence of minimal hepatic encephalopathy in cirrhotic patients. Ann Hepatol. 2011;10:S40–S44.PubMed
14.
go back to reference Agrawal S, Umapathy S, Dhiman RK. Minimal hepatic encephalopathy impairs quality of life. J Clin Exp Hepatol. 2015;5:S42–S48.CrossRefPubMed Agrawal S, Umapathy S, Dhiman RK. Minimal hepatic encephalopathy impairs quality of life. J Clin Exp Hepatol. 2015;5:S42–S48.CrossRefPubMed
15.
go back to reference Davalos Moscol M, Bustios SC. The burden of hepatic encephalopathy in Latin America. Ann Hepatol. 2011;10:S31–S35.PubMed Davalos Moscol M, Bustios SC. The burden of hepatic encephalopathy in Latin America. Ann Hepatol. 2011;10:S31–S35.PubMed
16.
go back to reference Desai AP, Reau N. The Burden of rehospitalization for patients with liver cirrhosis. Hosp Pract. 2016;44:60–69.CrossRef Desai AP, Reau N. The Burden of rehospitalization for patients with liver cirrhosis. Hosp Pract. 2016;44:60–69.CrossRef
17.
go back to reference Dasani BM, Sigal SH, Lieber CS. Analysis of risk factors for chronic hepatic encephalopathy: the role of Helicobacter pylori infection. Am J Gastroenterol. 1998;93:726–731.CrossRefPubMed Dasani BM, Sigal SH, Lieber CS. Analysis of risk factors for chronic hepatic encephalopathy: the role of Helicobacter pylori infection. Am J Gastroenterol. 1998;93:726–731.CrossRefPubMed
18.
go back to reference Calvet X, Nogueras C, Roque M, Sanfeliu I. Helicobacter pylori is not a risk factor for hepatic encephalopathy. Dig Liver Dis. 2001;33:414–419.CrossRefPubMed Calvet X, Nogueras C, Roque M, Sanfeliu I. Helicobacter pylori is not a risk factor for hepatic encephalopathy. Dig Liver Dis. 2001;33:414–419.CrossRefPubMed
19.
go back to reference Chakrabarti P, Zullo A, Hassan C, et al. Helicobacter pylori, gastric juice, and arterial ammonia levels in patients with cirrhosis. J Clin Gastroenterol. 2002;34:578–581.CrossRefPubMed Chakrabarti P, Zullo A, Hassan C, et al. Helicobacter pylori, gastric juice, and arterial ammonia levels in patients with cirrhosis. J Clin Gastroenterol. 2002;34:578–581.CrossRefPubMed
20.
go back to reference Gubbins GP, Moritz TE, Marsano LS, Talwalkar R, McClain CJ, Mendenhall CL. Helicobacter pylori is a risk factor for hepatic encephalopathy in acute alcoholic hepatitis: the ammonia hypothesis revisited. The Veterans Administration Cooperative Study Group No. 275. Am J Gastroenterol. 1993;88:1906–1910.PubMed Gubbins GP, Moritz TE, Marsano LS, Talwalkar R, McClain CJ, Mendenhall CL. Helicobacter pylori is a risk factor for hepatic encephalopathy in acute alcoholic hepatitis: the ammonia hypothesis revisited. The Veterans Administration Cooperative Study Group No. 275. Am J Gastroenterol. 1993;88:1906–1910.PubMed
21.
go back to reference Huber M, Rossle M, Siegerstetter V, et al. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis. Hepato Gastroenterol. 2001;48:541–544. Huber M, Rossle M, Siegerstetter V, et al. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis. Hepato Gastroenterol. 2001;48:541–544.
22.
go back to reference Kini D, Aggarwal R, Saraswat VA, Naik SR. Role of Helicobacter pylori infection in hyperammonemia and subclinical hepatic encephalopathy in cirrhosis of liver. Indian J Gastroenterol. 2001;20:237–240.PubMed Kini D, Aggarwal R, Saraswat VA, Naik SR. Role of Helicobacter pylori infection in hyperammonemia and subclinical hepatic encephalopathy in cirrhosis of liver. Indian J Gastroenterol. 2001;20:237–240.PubMed
23.
go back to reference Lalit Shrimali VC, Singh VB, Soni PK, Nayak KC, Gupta BK. Study of prevalence of H. pylori in hepatic encephalopathy due to various liver diseases. Indian Acad Clin Med. 2001;2:195–197. Lalit Shrimali VC, Singh VB, Soni PK, Nayak KC, Gupta BK. Study of prevalence of H. pylori in hepatic encephalopathy due to various liver diseases. Indian Acad Clin Med. 2001;2:195–197.
24.
go back to reference Kamran MSA, Abbas Z, Butt N, Lubna F, Awan S. Contribution of active H. Pylori infection and small intestinal bacterial overgrowth (SIBO) in cirrhotic patients with minimal hepatic encephalopathy. J Gastroenterol Hepatol. 2016;31:398. Kamran MSA, Abbas Z, Butt N, Lubna F, Awan S. Contribution of active H. Pylori infection and small intestinal bacterial overgrowth (SIBO) in cirrhotic patients with minimal hepatic encephalopathy. J Gastroenterol Hepatol. 2016;31:398.
25.
go back to reference Ramin Behroozian MF, Rahimi E. Association between Helicobacter pylori seropositivity and hepatic encephalopathy. Pak J Med Sci. 2010;26:547–550. Ramin Behroozian MF, Rahimi E. Association between Helicobacter pylori seropositivity and hepatic encephalopathy. Pak J Med Sci. 2010;26:547–550.
26.
go back to reference Naumovski-Mihalic S, Katicic M, Maricic V, et al. H. pylori infection and hepatic encephalopathy in cirrhotic patients: facts or fictions. Helicobacter. 2010;15:378–379. Naumovski-Mihalic S, Katicic M, Maricic V, et al. H. pylori infection and hepatic encephalopathy in cirrhotic patients: facts or fictions. Helicobacter. 2010;15:378–379.
27.
go back to reference Schulz C, Schutte K, Reisener N, Voss J, Malfertheiner P. Prevalence of Helicobacter pylori infection in patients with minimal hepatic encephalopathy. JGLD. 2016;25:191–195.PubMed Schulz C, Schutte K, Reisener N, Voss J, Malfertheiner P. Prevalence of Helicobacter pylori infection in patients with minimal hepatic encephalopathy. JGLD. 2016;25:191–195.PubMed
28.
go back to reference Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–605.CrossRefPubMed Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–605.CrossRefPubMed
29.
go back to reference Herzog R, Alvarez-Pasquin MJ, Diaz C, Del Barrio JL, Estrada JM, Gil A. Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Pub Health. 2013;13:154.CrossRef Herzog R, Alvarez-Pasquin MJ, Diaz C, Del Barrio JL, Estrada JM, Gil A. Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Pub Health. 2013;13:154.CrossRef
30.
32.
go back to reference Phongsamran PV, Kim JW, Cupo Abbott J, Rosenblatt A. Pharmacotherapy for hepatic encephalopathy. Drugs. 2010;70:1131–1148.CrossRefPubMed Phongsamran PV, Kim JW, Cupo Abbott J, Rosenblatt A. Pharmacotherapy for hepatic encephalopathy. Drugs. 2010;70:1131–1148.CrossRefPubMed
33.
go back to reference Mokuolu AO, Sigal SH, Lieber CS. Gastric juice urease activity as a diagnostic test for Helicobacter pylori infection. Am J Gastroenterol. 1997;92:644–648.PubMed Mokuolu AO, Sigal SH, Lieber CS. Gastric juice urease activity as a diagnostic test for Helicobacter pylori infection. Am J Gastroenterol. 1997;92:644–648.PubMed
34.
go back to reference Neithercut WD, Rowe PA, el Nujumi AM, Dahill S, McColl KE. Effect of Helicobacter pylori infection on intragastric urea and ammonium concentrations in patients with chronic renal failure. J Clin Pathol. 1993;46:544–547.CrossRefPubMedPubMedCentral Neithercut WD, Rowe PA, el Nujumi AM, Dahill S, McColl KE. Effect of Helicobacter pylori infection on intragastric urea and ammonium concentrations in patients with chronic renal failure. J Clin Pathol. 1993;46:544–547.CrossRefPubMedPubMedCentral
35.
go back to reference Lai D, Gorbach SL, Levitan R. Intestinal microflora in patients with alcoholic cirrhosis: urea-splitting bacteria and neomycin resistance. Gastroenterology. 1972;62:275–279.PubMed Lai D, Gorbach SL, Levitan R. Intestinal microflora in patients with alcoholic cirrhosis: urea-splitting bacteria and neomycin resistance. Gastroenterology. 1972;62:275–279.PubMed
36.
go back to reference Triebling AT, Korsten MA, Dlugosz JW, Paronetto F, Lieber CS. Severity of Helicobacter-induced gastric injury correlates with gastric juice ammonia. Dig Dis Sci. 1991;36:1089–1096.CrossRefPubMed Triebling AT, Korsten MA, Dlugosz JW, Paronetto F, Lieber CS. Severity of Helicobacter-induced gastric injury correlates with gastric juice ammonia. Dig Dis Sci. 1991;36:1089–1096.CrossRefPubMed
37.
go back to reference Webster LT Jr, Gabuzda GJ. Relation of azotemia to blood ammonium in patients with hepatic cirrhosis. AMA Arch Intern Med. 1959;103:15–22.CrossRefPubMed Webster LT Jr, Gabuzda GJ. Relation of azotemia to blood ammonium in patients with hepatic cirrhosis. AMA Arch Intern Med. 1959;103:15–22.CrossRefPubMed
38.
go back to reference Mobley HL, Hu LT, Foxal PA. Helicobacter pylori urease: properties and role in pathogenesis. Scand J Gastroenterol Suppl. 1991;187:39–46.CrossRefPubMed Mobley HL, Hu LT, Foxal PA. Helicobacter pylori urease: properties and role in pathogenesis. Scand J Gastroenterol Suppl. 1991;187:39–46.CrossRefPubMed
39.
go back to reference Suto H, Azuma T, Ito S, et al. Helicobacter pylori infection induces hyperammonaemia in Mongolian gerbils with liver cirrhosis. Gut. 2001;48:605–608.CrossRefPubMedPubMedCentral Suto H, Azuma T, Ito S, et al. Helicobacter pylori infection induces hyperammonaemia in Mongolian gerbils with liver cirrhosis. Gut. 2001;48:605–608.CrossRefPubMedPubMedCentral
41.
go back to reference Meyers S, Lieber CS. Reduction of gastric ammonia by ampicillin in normal and azotemic subjects. Gastroenterology. 1976;70:244–247.PubMed Meyers S, Lieber CS. Reduction of gastric ammonia by ampicillin in normal and azotemic subjects. Gastroenterology. 1976;70:244–247.PubMed
42.
go back to reference Munster DJ, Chapman BA, Burt MJ, et al. The fate of ingested 14C-urea in the urea breath test for Helicobacter pylori infection. Scand J Gastroenterol. 1993;28:661–666.CrossRefPubMed Munster DJ, Chapman BA, Burt MJ, et al. The fate of ingested 14C-urea in the urea breath test for Helicobacter pylori infection. Scand J Gastroenterol. 1993;28:661–666.CrossRefPubMed
43.
go back to reference Zullo A, Hassan C, Morini S. Hepatic encephalopathy and Helicobacter pylori: a critical reappraisal. J Clin Gastroenterol. 2003;37:164–168.CrossRefPubMed Zullo A, Hassan C, Morini S. Hepatic encephalopathy and Helicobacter pylori: a critical reappraisal. J Clin Gastroenterol. 2003;37:164–168.CrossRefPubMed
44.
go back to reference Schulz C, Schutte K, Malfertheiner P. Does H. pylori eradication therapy benefit patients with hepatic encephalopathy?: systematic review. J Clin Gastroenterol. 2014;48:491–499.PubMed Schulz C, Schutte K, Malfertheiner P. Does H. pylori eradication therapy benefit patients with hepatic encephalopathy?: systematic review. J Clin Gastroenterol. 2014;48:491–499.PubMed
45.
go back to reference Zullo A, Ridola L, De Francesco V, Hassan C. Helicobacter pylori eradication for hepatic encephalopathy treatment: the ideal study is still lacking! J Clin Gastroenterol. 2015;49:88–89.CrossRefPubMed Zullo A, Ridola L, De Francesco V, Hassan C. Helicobacter pylori eradication for hepatic encephalopathy treatment: the ideal study is still lacking! J Clin Gastroenterol. 2015;49:88–89.CrossRefPubMed
Metadata
Title
Association of Helicobacter pylori with the Risk of Hepatic Encephalopathy
Authors
Karn Wijarnpreecha
Supavit Chesdachai
Charat Thongprayoon
Veeravich Jaruvongvanich
Patompong Ungprasert
Wisit Cheungpasitporn
Publication date
01-12-2017
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 12/2017
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4834-1

Other articles of this Issue 12/2017

Digestive Diseases and Sciences 12/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.